Implantable Cytokine Factories Show Early Promise in First Human Trial for Advanced Ovarian Cancer
Patients with recurrent ovarian cancer often face limited treatment options because tumors become resistant to chemotherapy and spread throughout the abdominal cavity. Systemic immunotherapies can help some patients, but high dose cytokines such as interleukin 2 are too toxic when […]







